Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 14, 2019 ) Japan Conjugate Vaccine Market: Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. Japan is one of the most prominent markets of conjugate vaccines. Japan, at 84 years, has one of the highest life expectancies in the world. Currently, both PPSV23 and PCV13 are available for the elderly for the prevention of Streptococcus pneumoniae -related diseases. Despite these two vaccines being made available for the elderly, the national immunization program launched for these aged 65 and older as on October 1, 2014, only subsidized PPSV23. Japan has frequently reported low incidence of Meningococcal disease, and therefore the disease is not considered a high health care priority.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/japan-conjugate-vaccine-market/11301/#requestforsample
Market Segmentation:
Based on disease indication, the market is segmented into: o Pneumococcal o Haemophilus influenza type b o Diphtheria-tetanus-pertussis o Meningococcal o Others
Based on end user, the market is segmented into: o Paediatric o Adult
Key growth factors: Japan is projected to be a stable market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure and modernization of healthcare infrastructure will drive the Japan market for conjugate vaccines. Japan, with the highest life expectancy out of all other countries in the world, has its old population creating demand for adult conjugate vaccines.
Threats and key players:
1. Although the health situation in Japan is among the best in the world, there is still a significant gap to be filled, with regard to the use of vaccines to prevent severe infections. This gap has major implications for public health, both in Japan and other countries since Japan is cited as a source for infectious diseases to countries that have those diseases under better control through vaccination. There is also a need to organize an efficient immunization program, due to the limited resources for health care. Under-reporting, lack of awareness and focus on meningococcal disease are some of the major threats.
2. Major conjugate vaccine providers are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
....... Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/japan-conjugate-vaccine-market/11301/
Table Of Content
Chapter 1: Executive summary 1.1 Market scope and segmentation 1.2 Key questions answered in this study 1.3 Executive summary - I 1.4 Executive summary - II
Chapter 2: Market overview 2.1. Market definitions 2.2. Japan market overview by revenue - Japan historical (2015-2017) market revenue (USD Bn) - Japan forecasted (2018-2023) market revenue (USD Bn) 2.3. Japan market overview by volume - Japan historical (2015-2017) market volume (Million units) - Japan forecasted (2018-2023) market volume (Million units) 2.4. Japan market drivers and challenges 2.4.1. Japan market drivers 2.4.2. Japan market challenges 2.5. Japan market trends 2.6. Value chain
Chapter 3: Japan major segment overview - by disease indication 3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): Pneumococcal Japan (USD Bn, Million units) - Market share (2015, 2018 & 2023): Hib Japan (USD Bn, Million units) 3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): DTP Japan (USD Bn, Million units) - Market share (2015, 2018 & 2023): Meningococcal Japan (USD Bn, Million units)
Chapter 4: Japan major segment overview - by end user 4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR - Overview - by end user - Market share (2015, 2018 & 2023): Paediatric Japan (USD Bn, Million units) - Market share (2015, 2018 & 2023): Adult Japan (USD Bn, Million units) Chapter 5: Competitive landscape 5.1. Company market share - Top 5 companies 5.2. Company overview - GlaxoSmithKline - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.2(A) Executive profile GlaxoSmithKline 5.3. Company overview Pfizer Inc. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.3(A) Executive profile - Pfizer Inc. 5.4. Company overview Merck & Co. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.4(A) Executive profile - Merck & Co. 5.5. Company overview Novartis - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.5(A) Executive profile - Novartis 5.6. Company overview Sanofi Pasteur - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/japan-conjugate-vaccine-market/11301/#toc
Research Report Hub Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price. About US
Research Report Hub Sector 04, Plot 101, Sant Nagar, Moshi PCNDTA, Pune, 412105 Maharashtra, India
Web:www.researchreporthub.com Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Research Report Hub
Prakriti Mathur
+918448444687
sales@researchreporthub.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|